Reevaluating the Concept of Treating Experimental Tumors with a Mixed Bacterial Vaccine: Coley’s Toxin

Avitalized bacteria mediate tumor growth control via activation of innate immunity

(2011) Ulrike Klier et al.   CELLULAR IMMUNOLOGY

Toll-Like Receptor 4 Activation in Cancer Progression and Therapy

(2011) Alja Oblak et al.   Clinical & Developmental Immunology

CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice

(2011) C. Zoglmeier et al.   CLINICAL CANCER RESEARCH

The role of innate immunity in spontaneous regression of cancer

(2011) JA Thomas et al.   INDIAN JOURNAL OF CANCER

Pathogen Recognition by the Innate Immune System

(2011) Himanshu Kumar et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia

(2011) Clive S. Zent et al.   LEUKEMIA & LYMPHOMA

Prognostic factors for resectable pancreatic adenocarcinoma

(2011) C. Neuzillet et al.   Journal of Visceral Surgery

Testimony from the Bedside: From Coley's Toxins to Targeted Immunotherapy

(2010) Jin Mo Park et al.   CANCER CELL

TLR-signaling Networks

(2010) J. Brown et al.   JOURNAL OF DENTAL RESEARCH

Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited

(2009) William K. Decker et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells

(2009) C. A. Corzo et al.   JOURNAL OF IMMUNOLOGY

Lysates of S. pyogenes Serotype M49 Induce Pancreatic Tumor Growth Delay by Specific and Unspecific Antitumor Immune Responses

(2008) Michael Linnebacher et al.   JOURNAL OF IMMUNOTHERAPY